TGF-β Signaling in Progression of Oral Cancer
International Journal of Molecular Sciences · 17.06.2023 · 24 (12) · 10263
DOI: 10.3390/ijms241210263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.06.2023. Verfasst von Yuanyuan Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Shenzhen University Medicine School, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Mouth Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Young Innovative Talents Project, Innovation and Entrepreneurship Training Program for College Students, Shenzhen Overseas Talent Program.
Abstract (Originalsprache)
Oral cancer is a common malignancy worldwide, accounting for 1.9% to 3.5% of all malignant tumors. Transforming growth factor β (TGF-β), as one of the most important cytokines, is found to play complex and crucial roles in oral cancers. It may act in a pro-tumorigenic and tumor-suppressive manner; activities of the former include cell cycle progression inhibition, tumor microenvironment preparation, apoptosis promotion, stimulation of cancer cell invasion and metastasis, and suppression of immune surveillance. However, the triggering mechanisms of these distinct actions remain unclear. This review summarizes the molecular mechanisms of TGF-β signal transduction, focusing on oral squamous cell and salivary adenoid systemic carcinomas as well as keratocystic odontogenic tumors. Both the supporting and contrary evidence of the roles of TGF-β is discussed. Importantly, the TGF-β pathway has been the target of new drugs developed in the past decade, some having demonstrated promising therapeutic effects in clinical trials. Therefore, the achievements of TGF-β pathway-based therapeutics and their challenges are also assessed. The summarization and discussion of the updated knowledge of TGF-β signaling pathways will provide insight into the design of new strategies for oral cancer treatment, leading to an improvement in oral cancer outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Shenzhen University Medicine School, Shenzhen University, Shenzhen 518060, China.
- Key Laboratory of Optoelectronic Devices and Systems, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
- Central Laboratory, Peking University School of Stomatology, Beijing 100081, China.
Förderung
- Guangdong Young Innovative Talents Project
- Innovation and Entrepreneurship Training Program for College Students
- Shenzhen Overseas Talent Program
- The National Natural Science Foundation of China
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Guo, Y., Xu, T., Chai, Y., & Chen, F. (2023). TGF-β Signaling in Progression of Oral Cancer. International Journal of Molecular Sciences, 24(12), 10263. https://doi.org/10.3390/ijms241210263
Vancouver
Guo Y, Xu T, Chai Y, Chen F. TGF-β Signaling in Progression of Oral Cancer. International Journal of Molecular Sciences. 2023;24(12):10263. doi:10.3390/ijms241210263
BibTeX
@article{Guo2023,
author = {Guo, Yuanyuan and Xu, Tiansong and Chai, Yujuan and Chen, Feng},
title = {TGF-β Signaling in Progression of Oral Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {12},
pages = {10263},
doi = {10.3390/ijms241210263}
}
EUVIMED